Drawing for SHEARSON HUTTON

USPTO serial 88900149

SHEARSON HUTTON

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
REEVES, APRIL ELIZABETH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SHEARSON HUTTON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Daniel S. Polley

Daniel S. Polley DANIEL S. POLLEY, P.A.7251 WEST PALMETTO PARK ROADSUITE 202BOCA RATON, FL 33433

Goods and services

ClassDescriptionStatusFirst use
035Investment trust services in the nature of marketing investment funds for othersACTIVE—
036Securities brokerage, investment brokerage, financial and investment consulting, and investment banking services; financial advisory and consultancy services; investment of funds for others; investment management; financial portfolio management; financial asset management; financial planning for retirement; financial administration of retirement plans; and financial services, namely, estate asset acquisition and estate settlement services; financial services, namely, investment analysis and advice; financial services, namely, investment planning and management; financial services, namely, investment fund transfer and transaction services; financial consultation services relating to stocks, bonds, securities, commodities, options, real estate, fixed income products, precious metals, cryptocurrencies, mutual funds and retirement plans; financial services, namely, money lending; financial services, namely, management of portfolios comprising investments and securities for others; providing financial services with respect to investment trust services, namely, creating, developing and managing investment funds for others; financial and investment services, namely, investment brokerage services, capital investment, investment banking and commodities and futures trading; financial portfolio management services; underwiting of securities for others and distribution of related reports and prospectuses in connection therewith; underwiting life insurance; life, health, variable annuities and fixed annuities insurance underwriting services; mortgage brokerage; real estate brokerageACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 6, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 5, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 1, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 6, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 6, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 16, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 1, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 1, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 1, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 1, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 9, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 9, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 9, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 29, 2020DOCKASSIGNED TO EXAMINER—
May 15, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 7, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance